Small-fiber Neuropathy in Chronic Kidney Disease
Recruitment status was Recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Neurological dysfunction is a common complication of late stage chronic kidney disease (CKD) and peripheral nerve system is often involved in such complication. Sensory disturbances such as paresthesia and hypoesthesia are the predominant symptoms in uremic polyneuropathy and it is traditionally thought the uremic polyneuropathy mainly involve large-diameter sensory nerves. However in uremic patients the abnormal thermal thresholds, the sensory symptoms like numbness, burning, paradoxical heat, cold or freezing, and pain, and the frequent symptoms of autonomic dysfunction suggest that small-fiber neuropathy should be a clinical entity in patients of CKD. But there are still few investigations with emphasis on the changes of small-fiber nerves in CKD, and little is known about the characteristics and mechanism of small-fiber neuropathy in CKD. Skin biopsy with evaluation of epidermal nerve density and the morphology of epidermal nerves and the subepidermal nerve plexus is an effective and minimally invasive test for assessment of small-fiber neuropathy. Contact heat evoked potential (CHEP) recording the brain responses evoked by contact heat stimuli on the skin is a non-invasive technique to investigate the thermo-nociceptive pathways mediated by small-fiber nerves. In the current study, we will use an integrated approach by combining the skin biopsy, quantitative sensory testing, autonomic function tests, and CHEP to investigate the pathological, psychophysical and physiological aspects of small-fiber neuropathy in patients of CKD. The aims of the current study is to address the following issues: (1) the changes of small fiber nerves in uremia and CKD of different stage; (2) the correlation of skin innervation with clinical manifestations, thermal thresholds, and autonomic function; (3) the influence of dialysis therapy, the type of dialysis therapy, or renal transplantation on the small fiber neuropathy in uremia; (4) the roles of blood chemical substances, metals, and endocrine profiles on the development of small-fiber neuropathy; (5) the relationship between the small-fiber neuropathy and pruritus or restless leg syndrome; and (6) the pathological and physiological correlates of painful symptoms by skin biopsy and CHEP in CKD related neuropathy. The results of the study will provide important insights in the understanding of the pathogenesis, and the prevention and new treatments of small-fiber neuropathy in CKD.
| Condition | Intervention |
|---|---|
|
Small-Fiber Neuropathy Chronic Kidney Disease |
Other: Skin biopsy |
| Study Type: | Interventional |
| Study Design: | Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic |
| Official Title: | Small-fiber Neuropathy in Chronic Kidney Disease |
- The pathology of skin biopsy [ Time Frame: within 3 months after inclusion ] [ Designated as safety issue: No ]
- Intraepidermal fiber density [ Time Frame: within 3 months after inclusion ] [ Designated as safety issue: No ]
- Autonomic function [ Time Frame: within 3 months after inclusion ] [ Designated as safety issue: No ]
- Function of small-fiber sensory nerve [ Time Frame: within 3 months after inclusion ] [ Designated as safety issue: No ]
| Estimated Enrollment: | 120 |
| Study Start Date: | February 2009 |
| Estimated Primary Completion Date: | August 2012 (Final data collection date for primary outcome measure) |
-
Other: Skin biopsy
Eligibility| Ages Eligible for Study: | 18 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
Inclusion Criteria:
- The patients should fulfill the criteria of CKD according to renal function study and the patients of end-stage renal disease should receive regular dialysis therapy and follow-up at outpatient clinics.
- For disease comparison, patients with peripheral neuropathy of variable etiologies will also be recruited.
Exclusion Criteria:
- Poor control DM,
- Severe heart failure,
- Bleeding tendency,
- Severe lung disease with respiratory distress,
- Severe infection,
- Alcoholism,
- Amyloidosis,
- Poor wound healing history.
Contacts and Locations| Contact: Sung-Tsang Hsieh, PhD | 886-2-23123456 ext 88182 | shsieh@ntu.edu.tw |
| Taiwan | |
| National Taiwan University Hospital | Recruiting |
| Taipei, Taiwan, 10002 | |
| Contact: Sung-Tsang Hsieh, PhD 886-2-23123456 ext 88182 shsieh@ntu.edu.tw | |
| Principal Investigator: Chi-Chao Chao, MD | |
| Study Director: | Sung-Tsang Hsieh | National Taiwan Univeristy Hospital |
More Information
No publications provided
| Responsible Party: | Chi-Chao, Chao, Department of Neurology, National Taiwan University Hospital |
| ClinicalTrials.gov Identifier: | NCT01078857 History of Changes |
| Other Study ID Numbers: | 200812088R |
| Study First Received: | February 28, 2010 |
| Last Updated: | March 1, 2010 |
| Health Authority: | Taiwan: Department of Health |
Keywords provided by National Taiwan University Hospital:
|
Chronic kidney disease Small-fiber neuropathy Skin biopsy |
Contact heat evoked potential Autonomic neuropathy Neuropathy in late stage chronic kidney disease |
Additional relevant MeSH terms:
|
Kidney Diseases Renal Insufficiency, Chronic Kidney Failure, Chronic Demyelinating Diseases Polyneuropathies Nerve Compression Syndromes Neurologic Manifestations Neurotoxicity Syndromes |
Urologic Diseases Renal Insufficiency Nervous System Diseases Peripheral Nervous System Diseases Neuromuscular Diseases Signs and Symptoms Poisoning Substance-Related Disorders |
ClinicalTrials.gov processed this record on May 22, 2013